

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | microglial cell activation (GO:0001774) | 5.77816563 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.73518992 |
| 3 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.30229712 |
| 4 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.30229712 |
| 5 | modulation by symbiont of host immune response (GO:0052553) | 5.30229712 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 5.30229712 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 5.30229712 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.30229712 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 5.22142883 |
| 10 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.02405951 |
| 11 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.90199435 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.67953013 |
| 13 | detection of molecule of bacterial origin (GO:0032490) | 4.45578305 |
| 14 | negative regulation of interleukin-12 production (GO:0032695) | 4.40047270 |
| 15 | detection of other organism (GO:0098543) | 4.37189244 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.23365336 |
| 17 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.21120824 |
| 18 | macrophage activation (GO:0042116) | 4.11013419 |
| 19 | detection of external biotic stimulus (GO:0098581) | 4.02856728 |
| 20 | detection of bacterium (GO:0016045) | 3.98072870 |
| 21 | respiratory burst (GO:0045730) | 3.94545144 |
| 22 | regulation of gamma-delta T cell activation (GO:0046643) | 3.92339499 |
| 23 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.85626064 |
| 24 | immunoglobulin mediated immune response (GO:0016064) | 3.82714395 |
| 25 | response to peptidoglycan (GO:0032494) | 3.80978983 |
| 26 | positive regulation of interferon-alpha production (GO:0032727) | 3.70104349 |
| 27 | response to host immune response (GO:0052572) | 3.63479818 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.63479818 |
| 29 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.57255269 |
| 30 | positive regulation of mast cell degranulation (GO:0043306) | 3.57255269 |
| 31 | eosinophil chemotaxis (GO:0048245) | 3.55498596 |
| 32 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.55070088 |
| 33 | myeloid cell activation involved in immune response (GO:0002275) | 3.54512023 |
| 34 | detection of biotic stimulus (GO:0009595) | 3.54438027 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 3.53896432 |
| 36 | regulation of interferon-alpha production (GO:0032647) | 3.53516266 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.51512558 |
| 38 | negative regulation of cell killing (GO:0031342) | 3.45399095 |
| 39 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.45399095 |
| 40 | granulocyte activation (GO:0036230) | 3.43147159 |
| 41 | T-helper 1 type immune response (GO:0042088) | 3.37978549 |
| 42 | neutrophil activation (GO:0042119) | 3.34895261 |
| 43 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.30030757 |
| 44 | response to host (GO:0075136) | 3.29825465 |
| 45 | response to host defenses (GO:0052200) | 3.29825465 |
| 46 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.29825465 |
| 47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.28822331 |
| 48 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.28699014 |
| 49 | positive regulation of mast cell activation (GO:0033005) | 3.24649616 |
| 50 | regulation of mast cell degranulation (GO:0043304) | 3.23965149 |
| 51 | positive regulation of antigen processing and presentation (GO:0002579) | 3.20420428 |
| 52 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.19850128 |
| 53 | negative regulation of T cell mediated immunity (GO:0002710) | 3.18688051 |
| 54 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.17170482 |
| 55 | eosinophil migration (GO:0072677) | 3.14542343 |
| 56 | neutrophil mediated immunity (GO:0002446) | 3.13321827 |
| 57 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.09164197 |
| 58 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.08002997 |
| 59 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.05667224 |
| 60 | activated T cell proliferation (GO:0050798) | 3.05338315 |
| 61 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.02210823 |
| 62 | cellular response to ethanol (GO:0071361) | 3.00721471 |
| 63 | regulation of mast cell activation (GO:0033003) | 2.99753887 |
| 64 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.99032056 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.97305506 |
| 66 | phagosome maturation (GO:0090382) | 2.96691695 |
| 67 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.96366584 |
| 68 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.95364512 |
| 69 | regulation of hypersensitivity (GO:0002883) | 2.95118281 |
| 70 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.94365640 |
| 71 | myeloid leukocyte mediated immunity (GO:0002444) | 2.93732177 |
| 72 | cellular extravasation (GO:0045123) | 2.93647264 |
| 73 | superoxide anion generation (GO:0042554) | 2.90938755 |
| 74 | cellular response to zinc ion (GO:0071294) | 2.89134243 |
| 75 | negative regulation of mast cell activation (GO:0033004) | 2.88263826 |
| 76 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87327814 |
| 77 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.86873943 |
| 78 | defense response to protozoan (GO:0042832) | 2.85815245 |
| 79 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.84081780 |
| 80 | regulation of type 2 immune response (GO:0002828) | 2.83852315 |
| 81 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.82332363 |
| 82 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.82222605 |
| 83 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.81913808 |
| 84 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81895959 |
| 85 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.80274841 |
| 86 | myeloid leukocyte activation (GO:0002274) | 2.79410775 |
| 87 | regulation of B cell differentiation (GO:0045577) | 2.79322346 |
| 88 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.78297488 |
| 89 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.77925486 |
| 90 | adenosine receptor signaling pathway (GO:0001973) | 2.77844254 |
| 91 | cellular response to interferon-gamma (GO:0071346) | 2.77198299 |
| 92 | type I interferon signaling pathway (GO:0060337) | 2.75506375 |
| 93 | cellular response to type I interferon (GO:0071357) | 2.75506375 |
| 94 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.75354618 |
| 95 | regulation of monocyte chemotaxis (GO:0090025) | 2.73579292 |
| 96 | T cell migration (GO:0072678) | 2.73023402 |
| 97 | germinal center formation (GO:0002467) | 2.72081828 |
| 98 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.71560372 |
| 99 | positive regulation of macrophage cytokine production (GO:0060907) | 2.71170716 |
| 100 | response to type I interferon (GO:0034340) | 2.71149457 |
| 101 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.70899297 |
| 102 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.69783010 |
| 103 | interferon-gamma production (GO:0032609) | 2.69232143 |
| 104 | regulation of T cell tolerance induction (GO:0002664) | 2.69128275 |
| 105 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.68960772 |
| 106 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.68581976 |
| 107 | neutrophil chemotaxis (GO:0030593) | 2.67124698 |
| 108 | purinergic receptor signaling pathway (GO:0035587) | 2.66403798 |
| 109 | negative regulation of B cell proliferation (GO:0030889) | 2.66246497 |
| 110 | regulation of platelet aggregation (GO:0090330) | 2.61218680 |
| 111 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.60688877 |
| 112 | regulation of leukocyte degranulation (GO:0043300) | 2.60052200 |
| 113 | I-kappaB phosphorylation (GO:0007252) | 2.59644270 |
| 114 | neutrophil migration (GO:1990266) | 2.59010740 |
| 115 | granulocyte chemotaxis (GO:0071621) | 2.58839976 |
| 116 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.58503721 |
| 117 | positive regulation of type 2 immune response (GO:0002830) | 2.58066544 |
| 118 | mast cell activation (GO:0045576) | 2.57667161 |
| 119 | regulation of antigen processing and presentation (GO:0002577) | 2.57258157 |
| 120 | monocyte chemotaxis (GO:0002548) | 2.57068096 |
| 121 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.55786211 |
| 122 | response to muramyl dipeptide (GO:0032495) | 2.51521021 |
| 123 | positive regulation of leukocyte degranulation (GO:0043302) | 2.51139738 |
| 124 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.47409417 |
| 125 | granulocyte migration (GO:0097530) | 2.46828934 |
| 126 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.46385721 |
| 127 | presynaptic membrane assembly (GO:0097105) | 2.46243368 |
| 128 | neuron cell-cell adhesion (GO:0007158) | 2.46113717 |
| 129 | histamine secretion (GO:0001821) | 2.46015227 |
| 130 | positive regulation of interferon-beta production (GO:0032728) | 2.45833687 |
| 131 | B cell proliferation (GO:0042100) | 2.45777160 |
| 132 | response to protozoan (GO:0001562) | 2.43074868 |
| 133 | B cell mediated immunity (GO:0019724) | 2.42656913 |
| 134 | glycosphingolipid catabolic process (GO:0046479) | 2.39951683 |
| 135 | negative regulation of interleukin-17 production (GO:0032700) | 2.38958620 |
| 136 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.38795830 |
| 137 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.37630752 |
| 138 | positive regulation of B cell differentiation (GO:0045579) | 2.37205125 |
| 139 | leukocyte mediated cytotoxicity (GO:0001909) | 2.35865720 |
| 140 | lymphocyte chemotaxis (GO:0048247) | 2.34613356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.06299535 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.52681803 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.22812119 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.63118919 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.22628488 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10859504 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.65847876 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.64319554 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.53287403 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.50963253 |
| 11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.43632154 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.35846328 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.32774742 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08871435 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.03622400 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.98894475 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.96230441 |
| 18 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.91148797 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86465073 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.72297288 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.72078012 |
| 22 | MYB_26560356_Chip-Seq_TH2_Human | 1.70092321 |
| 23 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.66643750 |
| 24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65967497 |
| 25 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.59221240 |
| 26 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.58254303 |
| 27 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.58036693 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.54691463 |
| 29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.50005636 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.49473546 |
| 31 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46683199 |
| 32 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.46584969 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.45212387 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42061503 |
| 35 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.41186023 |
| 36 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.40978874 |
| 37 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.38806671 |
| 38 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37484554 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36948819 |
| 40 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36031461 |
| 41 | GATA3_26560356_Chip-Seq_TH2_Human | 1.34486258 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.34339526 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33935167 |
| 44 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.32780048 |
| 45 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.32619561 |
| 46 | P300_19829295_ChIP-Seq_ESCs_Human | 1.32508808 |
| 47 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31526211 |
| 48 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30799993 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.27852492 |
| 50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.25288165 |
| 51 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25099286 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24882787 |
| 53 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.24818531 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.22863159 |
| 55 | MYB_26560356_Chip-Seq_TH1_Human | 1.22332829 |
| 56 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.22331352 |
| 57 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.21136305 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18847852 |
| 59 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.18122105 |
| 60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16782934 |
| 61 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.15488289 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.14909040 |
| 63 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.14873136 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13619533 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12194608 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11908836 |
| 67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11119435 |
| 68 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.10310319 |
| 69 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08823425 |
| 70 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.07735893 |
| 71 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.07735893 |
| 72 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.07320751 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07247153 |
| 74 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06618054 |
| 75 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06219503 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05864390 |
| 77 | AR_25329375_ChIP-Seq_VCAP_Human | 1.05731758 |
| 78 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05618925 |
| 79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.04285409 |
| 80 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03326235 |
| 81 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.03169606 |
| 82 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03169606 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02263397 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.01237097 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00538100 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.00410697 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.00410697 |
| 88 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99976122 |
| 89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.99079385 |
| 90 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.99070002 |
| 91 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99011788 |
| 92 | MAF_26560356_Chip-Seq_TH1_Human | 0.98940785 |
| 93 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.98402719 |
| 94 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.97495050 |
| 95 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.95179247 |
| 96 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94331521 |
| 97 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93957935 |
| 98 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.93382328 |
| 99 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.93380180 |
| 100 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.93289704 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92910435 |
| 102 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.92713585 |
| 103 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92612734 |
| 104 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92609944 |
| 105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92580578 |
| 106 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92248486 |
| 107 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92147598 |
| 108 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92051700 |
| 109 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.91634820 |
| 110 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90604283 |
| 111 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90430885 |
| 112 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.90259693 |
| 113 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89508141 |
| 114 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88555270 |
| 115 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88286856 |
| 116 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87948101 |
| 117 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.87132889 |
| 118 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87074765 |
| 119 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.86946508 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86821811 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86698093 |
| 122 | RXR_22108803_ChIP-Seq_LS180_Human | 0.86530457 |
| 123 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86051504 |
| 124 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.85997153 |
| 125 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85989876 |
| 126 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.83749754 |
| 127 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.82353270 |
| 128 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.82082860 |
| 129 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81290011 |
| 130 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.80182873 |
| 131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80161612 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79651528 |
| 133 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.78911955 |
| 134 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78535023 |
| 135 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.78143972 |
| 136 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.78041662 |
| 137 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.78019899 |
| 138 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77908053 |
| 139 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.77248338 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77000769 |
| 141 | UTX_26944678_Chip-Seq_JUKART_Human | 0.76721807 |
| 142 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.75972070 |
| 143 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.74155490 |
| 144 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73887482 |
| 145 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.72973673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 4.51302748 |
| 2 | MP0003303_peritoneal_inflammation | 3.74454131 |
| 3 | MP0006082_CNS_inflammation | 3.36456211 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.19661131 |
| 5 | MP0005000_abnormal_immune_tolerance | 2.83844689 |
| 6 | MP0002419_abnormal_innate_immunity | 2.82891923 |
| 7 | MP0005387_immune_system_phenotype | 2.79534146 |
| 8 | MP0001790_abnormal_immune_system | 2.79534146 |
| 9 | MP0005671_abnormal_response_to | 2.72932903 |
| 10 | MP0003436_decreased_susceptibility_to | 2.68975192 |
| 11 | MP0003880_abnormal_central_pattern | 2.67358177 |
| 12 | MP0009785_altered_susceptibility_to | 2.65778054 |
| 13 | MP0004859_abnormal_synaptic_plasticity | 2.65096020 |
| 14 | MP0001800_abnormal_humoral_immune | 2.63113516 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.56715037 |
| 16 | MP0004510_myositis | 2.48625529 |
| 17 | MP0003690_abnormal_glial_cell | 2.44797779 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.41122845 |
| 19 | MP0005025_abnormal_response_to | 2.27049575 |
| 20 | * MP0002723_abnormal_immune_serum | 2.23050102 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.05570588 |
| 22 | * MP0001819_abnormal_immune_cell | 2.04076695 |
| 23 | * MP0002420_abnormal_adaptive_immunity | 2.02882991 |
| 24 | MP0003075_altered_response_to | 1.97297796 |
| 25 | MP0003300_gastrointestinal_ulcer | 1.96893151 |
| 26 | MP0003724_increased_susceptibility_to | 1.95238322 |
| 27 | MP0003172_abnormal_lysosome_physiology | 1.93892324 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.80591237 |
| 29 | MP0005310_abnormal_salivary_gland | 1.78787469 |
| 30 | MP0000685_abnormal_immune_system | 1.74026038 |
| 31 | MP0000569_abnormal_digit_pigmentation | 1.66806228 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.64693849 |
| 33 | MP0002064_seizures | 1.60267892 |
| 34 | MP0003635_abnormal_synaptic_transmissio | 1.59832036 |
| 35 | MP0005166_decreased_susceptibility_to | 1.57187706 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.53720578 |
| 37 | MP0005397_hematopoietic_system_phenotyp | 1.51590510 |
| 38 | MP0001545_abnormal_hematopoietic_system | 1.51590510 |
| 39 | MP0005423_abnormal_somatic_nervous | 1.50031822 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.49998919 |
| 41 | MP0009745_abnormal_behavioral_response | 1.48676701 |
| 42 | MP0002736_abnormal_nociception_after | 1.48651872 |
| 43 | MP0000604_amyloidosis | 1.47034204 |
| 44 | MP0009278_abnormal_bone_marrow | 1.43732461 |
| 45 | MP0009764_decreased_sensitivity_to | 1.43682713 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.42673554 |
| 47 | MP0002063_abnormal_learning/memory/cond | 1.42571280 |
| 48 | MP0008260_abnormal_autophagy | 1.42562619 |
| 49 | MP0002405_respiratory_system_inflammati | 1.39374591 |
| 50 | MP0005551_abnormal_eye_electrophysiolog | 1.37627238 |
| 51 | MP0000920_abnormal_myelination | 1.34548915 |
| 52 | MP0001853_heart_inflammation | 1.32712606 |
| 53 | * MP0000716_abnormal_immune_system | 1.30678178 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.30529342 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.26551806 |
| 56 | MP0002822_catalepsy | 1.26396892 |
| 57 | MP0009046_muscle_twitch | 1.26305028 |
| 58 | MP0002572_abnormal_emotion/affect_behav | 1.24829521 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.24108267 |
| 60 | MP0004270_analgesia | 1.23649398 |
| 61 | MP0003763_abnormal_thymus_physiology | 1.21570979 |
| 62 | MP0003656_abnormal_erythrocyte_physiolo | 1.21170367 |
| 63 | MP0002090_abnormal_vision | 1.20770328 |
| 64 | MP0001486_abnormal_startle_reflex | 1.19083903 |
| 65 | MP0002735_abnormal_chemical_nociception | 1.18811195 |
| 66 | MP0004883_abnormal_blood_vessel | 1.18741159 |
| 67 | MP0000343_altered_response_to | 1.18478670 |
| 68 | MP0005164_abnormal_response_to | 1.17913335 |
| 69 | MP0001440_abnormal_grooming_behavior | 1.15179186 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.15159336 |
| 71 | MP0008469_abnormal_protein_level | 1.15048479 |
| 72 | MP0003633_abnormal_nervous_system | 1.12699412 |
| 73 | MP0002332_abnormal_exercise_endurance | 1.10873931 |
| 74 | MP0005451_abnormal_body_composition | 1.09389777 |
| 75 | MP0002398_abnormal_bone_marrow | 1.08567398 |
| 76 | MP0002277_abnormal_respiratory_mucosa | 1.07049706 |
| 77 | MP0001851_eye_inflammation | 1.04859520 |
| 78 | MP0003866_abnormal_defecation | 1.04165395 |
| 79 | MP0001986_abnormal_taste_sensitivity | 0.96354239 |
| 80 | MP0004947_skin_inflammation | 0.96332019 |
| 81 | MP0009840_abnormal_foam_cell | 0.95902250 |
| 82 | MP0002067_abnormal_sensory_capabilities | 0.95315484 |
| 83 | MP0000689_abnormal_spleen_morphology | 0.94805801 |
| 84 | MP0008004_abnormal_stomach_pH | 0.94339902 |
| 85 | MP0005253_abnormal_eye_physiology | 0.93692024 |
| 86 | MP0004742_abnormal_vestibular_system | 0.91056349 |
| 87 | * MP0002429_abnormal_blood_cell | 0.90804798 |
| 88 | MP0002006_tumorigenesis | 0.90363457 |
| 89 | MP0002638_abnormal_pupillary_reflex | 0.89810650 |
| 90 | MP0003634_abnormal_glial_cell | 0.88931431 |
| 91 | MP0003448_altered_tumor_morphology | 0.88916334 |
| 92 | MP0003787_abnormal_imprinting | 0.88721331 |
| 93 | MP0009333_abnormal_splenocyte_physiolog | 0.86887367 |
| 94 | MP0008874_decreased_physiological_sensi | 0.86264539 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.83029048 |
| 96 | MP0003329_amyloid_beta_deposits | 0.82617838 |
| 97 | MP0001970_abnormal_pain_threshold | 0.81703948 |
| 98 | MP0003631_nervous_system_phenotype | 0.81036754 |
| 99 | MP0002272_abnormal_nervous_system | 0.80912577 |
| 100 | MP0005646_abnormal_pituitary_gland | 0.79367377 |
| 101 | MP0000858_altered_metastatic_potential | 0.79326074 |
| 102 | MP0010155_abnormal_intestine_physiology | 0.78462555 |
| 103 | MP0002733_abnormal_thermal_nociception | 0.78297122 |
| 104 | MP0002229_neurodegeneration | 0.77349189 |
| 105 | MP0004858_abnormal_nervous_system | 0.77174774 |
| 106 | MP0009763_increased_sensitivity_to | 0.76641174 |
| 107 | MP0003045_fibrosis | 0.76596891 |
| 108 | MP0000371_diluted_coat_color | 0.75811883 |
| 109 | MP0003828_pulmonary_edema | 0.75474445 |
| 110 | MP0000778_abnormal_nervous_system | 0.75219108 |
| 111 | MP0005174_abnormal_tail_pigmentation | 0.74065411 |
| 112 | MP0002734_abnormal_mechanical_nocicepti | 0.73929399 |
| 113 | MP0005386_behavior/neurological_phenoty | 0.73666646 |
| 114 | MP0004924_abnormal_behavior | 0.73666646 |
| 115 | MP0002138_abnormal_hepatobiliary_system | 0.73195567 |
| 116 | MP0001663_abnormal_digestive_system | 0.71988903 |
| 117 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71718380 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.70593241 |
| 119 | MP0003011_delayed_dark_adaptation | 0.69879702 |
| 120 | MP0002722_abnormal_immune_system | 0.69284988 |
| 121 | MP0004811_abnormal_neuron_physiology | 0.68195939 |
| 122 | MP0003195_calcinosis | 0.66637845 |
| 123 | MP0000249_abnormal_blood_vessel | 0.66347578 |
| 124 | MP0004381_abnormal_hair_follicle | 0.65875961 |
| 125 | MP0000703_abnormal_thymus_morphology | 0.65734104 |
| 126 | MP0003632_abnormal_nervous_system | 0.64696984 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.63650954 |
| 128 | MP0005075_abnormal_melanosome_morpholog | 0.62448084 |
| 129 | MP0005535_abnormal_body_temperature | 0.59753900 |
| 130 | MP0002009_preneoplasia | 0.58707652 |
| 131 | MP0006054_spinal_hemorrhage | 0.57844730 |
| 132 | MP0003091_abnormal_cell_migration | 0.56385080 |
| 133 | MP0008877_abnormal_DNA_methylation | 0.56274691 |
| 134 | MP0004130_abnormal_muscle_cell | 0.55870315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.81765078 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 6.56197934 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.74480375 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.06542344 |
| 5 | Systemic lupus erythematosus (HP:0002725) | 4.94982854 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.37294087 |
| 7 | Glomerulonephritis (HP:0000099) | 4.04920174 |
| 8 | Recurrent skin infections (HP:0001581) | 3.89803069 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.81369181 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.81369181 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.81369181 |
| 12 | Disinhibition (HP:0000734) | 3.78700226 |
| 13 | Abnormality of macrophages (HP:0004311) | 3.74905302 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.51770385 |
| 15 | Obstructive lung disease (HP:0006536) | 3.51770385 |
| 16 | Increased cerebral lipofuscin (HP:0011813) | 3.48846139 |
| 17 | Stomatitis (HP:0010280) | 3.43721439 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.33587290 |
| 19 | Gingivitis (HP:0000230) | 3.31924376 |
| 20 | Cellulitis (HP:0100658) | 3.20647971 |
| 21 | Hemoptysis (HP:0002105) | 3.20631118 |
| 22 | Congenital stationary night blindness (HP:0007642) | 3.20314743 |
| 23 | Agammaglobulinemia (HP:0004432) | 3.20069017 |
| 24 | Prostate neoplasm (HP:0100787) | 3.13738389 |
| 25 | Gastrointestinal stroma tumor (HP:0100723) | 3.12697375 |
| 26 | Mutism (HP:0002300) | 3.12615537 |
| 27 | T lymphocytopenia (HP:0005403) | 3.10216609 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 3.09693114 |
| 29 | Inappropriate behavior (HP:0000719) | 3.09247067 |
| 30 | Vasculitis (HP:0002633) | 3.03122844 |
| 31 | Encephalitis (HP:0002383) | 2.99441929 |
| 32 | Recurrent fungal infections (HP:0002841) | 2.95932340 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 2.91373130 |
| 34 | Keratoconjunctivitis (HP:0001096) | 2.89589584 |
| 35 | Abnormality of T cell number (HP:0011839) | 2.88661768 |
| 36 | Recurrent pneumonia (HP:0006532) | 2.88287246 |
| 37 | Colitis (HP:0002583) | 2.83924505 |
| 38 | Meningitis (HP:0001287) | 2.83392505 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.81500669 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.77913535 |
| 41 | Agnosia (HP:0010524) | 2.72818775 |
| 42 | Focal motor seizures (HP:0011153) | 2.72796862 |
| 43 | Recurrent viral infections (HP:0004429) | 2.71891595 |
| 44 | Epileptic encephalopathy (HP:0200134) | 2.66521210 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.65360599 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.65360599 |
| 47 | Chest pain (HP:0100749) | 2.63896978 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.62103267 |
| 49 | Neurofibrillary tangles (HP:0002185) | 2.61982291 |
| 50 | Myositis (HP:0100614) | 2.59733899 |
| 51 | Progressive visual loss (HP:0000529) | 2.54445946 |
| 52 | Dysostosis multiplex (HP:0000943) | 2.53886395 |
| 53 | Orchitis (HP:0100796) | 2.52436984 |
| 54 | Recurrent sinusitis (HP:0011108) | 2.51066985 |
| 55 | Papilledema (HP:0001085) | 2.50519373 |
| 56 | Autoimmune thrombocytopenia (HP:0001973) | 2.49781241 |
| 57 | Amyloidosis (HP:0011034) | 2.49424059 |
| 58 | Pulmonary embolism (HP:0002204) | 2.48088722 |
| 59 | Leukocytosis (HP:0001974) | 2.47918246 |
| 60 | Osteomyelitis (HP:0002754) | 2.46701795 |
| 61 | Febrile seizures (HP:0002373) | 2.44682911 |
| 62 | Recurrent lower respiratory tract infections (HP:0002783) | 2.44210092 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.42394957 |
| 64 | Retrobulbar optic neuritis (HP:0100654) | 2.41624296 |
| 65 | Optic neuritis (HP:0100653) | 2.41624296 |
| 66 | Complement deficiency (HP:0004431) | 2.41581586 |
| 67 | Pulmonary infiltrates (HP:0002113) | 2.41469939 |
| 68 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.40442343 |
| 69 | Thick nail (HP:0001805) | 2.39998944 |
| 70 | Increased IgM level (HP:0003496) | 2.38480678 |
| 71 | Arterial thrombosis (HP:0004420) | 2.37071318 |
| 72 | Supranuclear gaze palsy (HP:0000605) | 2.37026825 |
| 73 | Axonal loss (HP:0003447) | 2.36339812 |
| 74 | Chronic diarrhea (HP:0002028) | 2.30476078 |
| 75 | Gingival bleeding (HP:0000225) | 2.30375122 |
| 76 | Abnormality of the pleura (HP:0002103) | 2.29416245 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.28465675 |
| 78 | Memory impairment (HP:0002354) | 2.25326892 |
| 79 | Gangrene (HP:0100758) | 2.25069874 |
| 80 | Hematochezia (HP:0002573) | 2.20903710 |
| 81 | Neuronal loss in central nervous system (HP:0002529) | 2.19638091 |
| 82 | J-shaped sella turcica (HP:0002680) | 2.19196910 |
| 83 | Nephritis (HP:0000123) | 2.18630871 |
| 84 | Prolonged bleeding time (HP:0003010) | 2.16231322 |
| 85 | Basal ganglia calcification (HP:0002135) | 2.15736138 |
| 86 | Cerebral inclusion bodies (HP:0100314) | 2.14713399 |
| 87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.11594922 |
| 88 | Polyneuropathy (HP:0001271) | 2.10907256 |
| 89 | Epistaxis (HP:0000421) | 2.10547304 |
| 90 | Retinal atrophy (HP:0001105) | 2.10418027 |
| 91 | Abnormality of complement system (HP:0005339) | 2.09159322 |
| 92 | Sepsis (HP:0100806) | 2.08871109 |
| 93 | Lymphopenia (HP:0001888) | 2.08592849 |
| 94 | Choroideremia (HP:0001139) | 2.08512883 |
| 95 | Vertigo (HP:0002321) | 2.08030794 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.08015457 |
| 97 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.07866128 |
| 98 | Amyotrophic lateral sclerosis (HP:0007354) | 2.06413079 |
| 99 | Thyroiditis (HP:0100646) | 2.05418148 |
| 100 | Episodic fever (HP:0001954) | 2.01929162 |
| 101 | Pustule (HP:0200039) | 2.01910304 |
| 102 | Agitation (HP:0000713) | 2.00060977 |
| 103 | Pigmentary retinal degeneration (HP:0001146) | 1.99830160 |
| 104 | Urticaria (HP:0001025) | 1.97791550 |
| 105 | Restrictive lung disease (HP:0002091) | 1.97570300 |
| 106 | Hemiplegia (HP:0002301) | 1.97410052 |
| 107 | Hyperventilation (HP:0002883) | 1.97364653 |
| 108 | Anorexia (HP:0002039) | 1.96384639 |
| 109 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95640461 |
| 110 | Loss of speech (HP:0002371) | 1.95342235 |
| 111 | Urethral obstruction (HP:0000796) | 1.95281905 |
| 112 | Interstitial pulmonary disease (HP:0006530) | 1.95199587 |
| 113 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95113038 |
| 114 | Abnormality of the prostate (HP:0008775) | 1.94314393 |
| 115 | Abnormality of T cells (HP:0002843) | 1.93010550 |
| 116 | Apathy (HP:0000741) | 1.92294853 |
| 117 | Dyschromatopsia (HP:0007641) | 1.92189149 |
| 118 | Focal seizures (HP:0007359) | 1.91604590 |
| 119 | Excessive salivation (HP:0003781) | 1.89919584 |
| 120 | Drooling (HP:0002307) | 1.89919584 |
| 121 | Global brain atrophy (HP:0002283) | 1.86929255 |
| 122 | Recurrent bronchitis (HP:0002837) | 1.86378484 |
| 123 | Upper motor neuron abnormality (HP:0002127) | 1.86196111 |
| 124 | Periodontitis (HP:0000704) | 1.85130587 |
| 125 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.83506681 |
| 126 | Viral hepatitis (HP:0006562) | 1.81897415 |
| 127 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.81721025 |
| 128 | Keratitis (HP:0000491) | 1.81308496 |
| 129 | Abnormality of salivation (HP:0100755) | 1.81280643 |
| 130 | Abolished electroretinogram (ERG) (HP:0000550) | 1.80559314 |
| 131 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79825099 |
| 132 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79825099 |
| 133 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79825099 |
| 134 | Emphysema (HP:0002097) | 1.79475257 |
| 135 | Glomerulopathy (HP:0100820) | 1.78614912 |
| 136 | Abnormality of binocular vision (HP:0011514) | 1.76264738 |
| 137 | Diplopia (HP:0000651) | 1.76264738 |
| 138 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.75694538 |
| 139 | Spontaneous hematomas (HP:0007420) | 1.75109552 |
| 140 | Chronic sinusitis (HP:0011109) | 1.74644088 |
| 141 | Diminished motivation (HP:0000745) | 1.74400874 |
| 142 | IgM deficiency (HP:0002850) | 1.74322445 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.83070862 |
| 2 | BLK | 3.46385678 |
| 3 | MAP3K14 | 2.91286379 |
| 4 | GRK7 | 2.73838333 |
| 5 | MAP4K1 | 2.64508014 |
| 6 | TYK2 | 2.58186016 |
| 7 | CASK | 2.55380813 |
| 8 | TGFBR2 | 2.28237458 |
| 9 | MAP3K9 | 2.18690931 |
| 10 | MARK1 | 2.12016304 |
| 11 | PBK | 1.96622078 |
| 12 | BMPR2 | 1.93607115 |
| 13 | IRAK4 | 1.92784823 |
| 14 | CSF1R | 1.82699970 |
| 15 | FGR | 1.77211004 |
| 16 | NTRK3 | 1.76120910 |
| 17 | JAK1 | 1.72908679 |
| 18 | SYK | 1.72219233 |
| 19 | TBK1 | 1.67861356 |
| 20 | MAP3K13 | 1.64899668 |
| 21 | TXK | 1.64747166 |
| 22 | IRAK3 | 1.60103116 |
| 23 | SIK2 | 1.57876279 |
| 24 | FRK | 1.54826365 |
| 25 | IKBKB | 1.54467453 |
| 26 | MAP3K12 | 1.49322416 |
| 27 | FES | 1.44080561 |
| 28 | EPHA4 | 1.38033381 |
| 29 | LYN | 1.35384739 |
| 30 | MAP2K3 | 1.34426701 |
| 31 | DAPK2 | 1.31203314 |
| 32 | KIT | 1.30594955 |
| 33 | GRK1 | 1.28751225 |
| 34 | HCK | 1.20657413 |
| 35 | PLK2 | 1.19518775 |
| 36 | NEK9 | 1.18707976 |
| 37 | GRK5 | 1.17947353 |
| 38 | TNK2 | 1.17013660 |
| 39 | IKBKE | 1.16297310 |
| 40 | SIK3 | 1.15588398 |
| 41 | CSK | 1.15441182 |
| 42 | PDK2 | 1.14808048 |
| 43 | MATK | 1.09870533 |
| 44 | MAP2K7 | 1.08863362 |
| 45 | CLK1 | 1.07783581 |
| 46 | ITK | 1.06647991 |
| 47 | PIK3CG | 1.05246109 |
| 48 | PRPF4B | 1.05187106 |
| 49 | IRAK1 | 1.03744084 |
| 50 | ARAF | 1.01278641 |
| 51 | MAPK7 | 1.00616980 |
| 52 | MAPK12 | 0.99285821 |
| 53 | ERN1 | 0.98825473 |
| 54 | EPHA3 | 0.92957986 |
| 55 | PDK1 | 0.91377337 |
| 56 | MAP4K2 | 0.90767957 |
| 57 | IRAK2 | 0.90485141 |
| 58 | ADRBK2 | 0.90363027 |
| 59 | MARK2 | 0.90131659 |
| 60 | MAPK13 | 0.89060958 |
| 61 | MARK3 | 0.86919362 |
| 62 | MINK1 | 0.85799934 |
| 63 | ERBB3 | 0.85414077 |
| 64 | PKN1 | 0.80877641 |
| 65 | MAP3K2 | 0.80098386 |
| 66 | LCK | 0.79604554 |
| 67 | CAMKK1 | 0.78677742 |
| 68 | EIF2AK2 | 0.77008554 |
| 69 | TAOK1 | 0.76800183 |
| 70 | ACVR1B | 0.75256833 |
| 71 | MAP3K5 | 0.74798252 |
| 72 | YES1 | 0.74467318 |
| 73 | EPHB1 | 0.74021164 |
| 74 | MAP3K1 | 0.72432454 |
| 75 | MOS | 0.72096770 |
| 76 | BMPR1B | 0.71782320 |
| 77 | PRKCQ | 0.71675902 |
| 78 | CHUK | 0.70365830 |
| 79 | FYN | 0.69382848 |
| 80 | GRK6 | 0.69333609 |
| 81 | JAK2 | 0.68328904 |
| 82 | PDPK1 | 0.68259446 |
| 83 | MAP3K6 | 0.66933604 |
| 84 | CDK5 | 0.66591892 |
| 85 | NEK6 | 0.66441934 |
| 86 | PAK6 | 0.66037860 |
| 87 | KSR1 | 0.64640329 |
| 88 | DAPK1 | 0.62322885 |
| 89 | MAP3K11 | 0.61796901 |
| 90 | MAP3K3 | 0.61680115 |
| 91 | CDC42BPA | 0.60176724 |
| 92 | SGK3 | 0.59373672 |
| 93 | DYRK1B | 0.58287343 |
| 94 | KSR2 | 0.57556772 |
| 95 | PRKCH | 0.57021480 |
| 96 | CDK19 | 0.56193188 |
| 97 | PRKCD | 0.56188868 |
| 98 | BTK | 0.55892849 |
| 99 | CAMK1G | 0.55298672 |
| 100 | EGFR | 0.53913753 |
| 101 | TEC | 0.53724411 |
| 102 | SGK2 | 0.53356844 |
| 103 | MAP3K4 | 0.51430775 |
| 104 | PIM1 | 0.50763458 |
| 105 | NTRK2 | 0.49026321 |
| 106 | PRKCZ | 0.47837897 |
| 107 | CAMK1D | 0.46705421 |
| 108 | DYRK3 | 0.46397016 |
| 109 | CCNB1 | 0.45654929 |
| 110 | FGFR3 | 0.45472872 |
| 111 | SGK1 | 0.45075281 |
| 112 | CDK6 | 0.44708070 |
| 113 | ABL1 | 0.44489271 |
| 114 | MAP2K4 | 0.42724536 |
| 115 | CAMK4 | 0.41732535 |
| 116 | CAMKK2 | 0.41395421 |
| 117 | PRKCE | 0.41315077 |
| 118 | PTK2B | 0.41025682 |
| 119 | ZAP70 | 0.40288535 |
| 120 | TNIK | 0.40088996 |
| 121 | TAOK3 | 0.39045841 |
| 122 | JAK3 | 0.38702184 |
| 123 | OXSR1 | 0.38700904 |
| 124 | STK11 | 0.37838050 |
| 125 | SGK223 | 0.36408832 |
| 126 | SGK494 | 0.36408832 |
| 127 | CAMK2A | 0.35855144 |
| 128 | DYRK1A | 0.35329786 |
| 129 | STK10 | 0.34399847 |
| 130 | NLK | 0.33935710 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.87686577 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.49530899 |
| 3 | Phototransduction_Homo sapiens_hsa04744 | 2.38863042 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.34545590 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.16841387 |
| 6 | Tuberculosis_Homo sapiens_hsa05152 | 2.02194139 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01150140 |
| 8 | Pertussis_Homo sapiens_hsa05133 | 1.88293162 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.84526538 |
| 10 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.84096794 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79295630 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 1.74624837 |
| 13 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.64241686 |
| 14 | Phagosome_Homo sapiens_hsa04145 | 1.62341869 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 1.58643425 |
| 16 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.58298603 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.57167452 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.55166941 |
| 19 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.55049323 |
| 20 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.52305816 |
| 21 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.46202519 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.45677603 |
| 23 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.45056384 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44546839 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43830903 |
| 26 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.42758283 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.40833010 |
| 28 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39784741 |
| 29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.36734140 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.33902069 |
| 31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.33740893 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.33142130 |
| 33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27449523 |
| 34 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.27339854 |
| 35 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.24201957 |
| 36 | Morphine addiction_Homo sapiens_hsa05032 | 1.23165963 |
| 37 | Olfactory transduction_Homo sapiens_hsa04740 | 1.22743267 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.20020739 |
| 39 | Malaria_Homo sapiens_hsa05144 | 1.18505896 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.16760076 |
| 41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.15659656 |
| 42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.15153475 |
| 43 | Asthma_Homo sapiens_hsa05310 | 1.14758737 |
| 44 | Measles_Homo sapiens_hsa05162 | 1.14235094 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.14229537 |
| 46 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.13413956 |
| 47 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08322101 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 1.04906212 |
| 49 | Renin secretion_Homo sapiens_hsa04924 | 1.04073236 |
| 50 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03867670 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 1.02866309 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98708992 |
| 53 | Prion diseases_Homo sapiens_hsa05020 | 0.97576917 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.97358363 |
| 55 | Salivary secretion_Homo sapiens_hsa04970 | 0.93908561 |
| 56 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.91999192 |
| 57 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.87051365 |
| 58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86704077 |
| 59 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85816584 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 0.81694102 |
| 61 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.81676106 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80974439 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.78488345 |
| 64 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.76927429 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75907708 |
| 66 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.74802207 |
| 67 | Long-term depression_Homo sapiens_hsa04730 | 0.74381037 |
| 68 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.73756649 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.72486114 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.72180410 |
| 71 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70933926 |
| 72 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.70564155 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70146350 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.69523902 |
| 75 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.68879780 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.68588782 |
| 77 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67847605 |
| 78 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.66257432 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65839231 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.65588172 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.64320439 |
| 82 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62892938 |
| 83 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62762308 |
| 84 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62516548 |
| 85 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.61393083 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60100538 |
| 87 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59637866 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58833272 |
| 89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57989615 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57826618 |
| 91 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.57421740 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.57383709 |
| 93 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56432626 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.56311355 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56147166 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.55810392 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54255383 |
| 98 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54207980 |
| 99 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.53539065 |
| 100 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53048322 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51401945 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.49430857 |
| 103 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47730937 |
| 104 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.47188232 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46687425 |
| 106 | Glioma_Homo sapiens_hsa05214 | 0.46418499 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46049949 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44807426 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43157173 |
| 110 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42866673 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41224162 |
| 112 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39166622 |
| 113 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36758190 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35902161 |
| 115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33896045 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.33651739 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32651242 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.32333702 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.29611804 |
| 120 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.29113188 |

